无尽方舟
科学智能
无尽方舟是一家专注于 AI 生物医药的创新公司，围绕衰老干预与延寿药物发现搭建跨物种研发平台。公司通过自研 H2P 模型提升小鼠研究向人类应用转化的效率，并以宠物健康市场作为早期商业化切入点，在降低临床与伦理风险的同时验证产品价值，具备成长为全球抗衰老药物研发平台的潜力。
EonArk is an AI-enabled biotechnology company focused on aging intervention and longevity drug discovery. Through its proprietary H2P model, the company aims to improve the translation of findings from mouse studies to human applications, while using the pet health market as an early commercialization path to validate product value with lower clinical and ethical risk. EonArk has the potential to develop into a global platform for anti-aging drug discovery.
